Identification of the cold receptor TRPM8 in the nasal mucosa

Shao Cheng Liu, Hsuan Hsuan Lu, Li Hsiang Cheng, Yueng Hsiang Chu, Fei Peng Lee, Chi Chung Wu, Hsing Won Wang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: The transient receptor potential channel melastatin 8 (TRPM8) has been proposed to be a cold receptor. However, its distribution and physiologic role in the nose is not yet fully explored. Objective: We investigated the expression of TRPM8 in human nasal mucosa and its function when using the TRPM8 agonist. Methods: Immunohistochemistry was used to study TRPM8 receptors in the nasal mucosa from patients with and those without allergic rhinitis (AR). By using isometric contraction studies, we also tested the effectiveness of the TRPM8 agonist menthol on nasal mucosa. Changes in nasal mucosal contractility in response to the application of the adrenergic agent methoxamine were also measured. We explored the effect of menthol on electrical field stimulation (EFS) induced nasal mucosal contractions. Results: TRPM8 immunoreactivity was present principally in the nasal cilia, epithelium, and subepithelium around the glands. Except for nerve fibers, no obvious TRPM8-immunoreactive cells were detected in connective tissues. The immunoreactivity revealed no significant difference between patients with AR and those without AR. Adding menthol had a negligible effect on the basal tension of the nasal mucosa, but higher doses of menthol had a significant spasmolytic effect on nasal mucosa precontracted with methoxamine. Menthol inhibited the spike contraction induced by EFS, even at low doses. Conclusions: The finding of the TRPM8 immunoreactivity underlines the important physiologic role of the nose in temperature regulation, both in patients with allergy and those without allergy. Isometric contraction studies demonstrate the role of TRPM8 in regulating nasal patency and airway resistance. The antiadrenergic effect of menthol showed an effect apparently opposite that of clinical observations, that we usually feel decongested after menthol inhalation. The underlying mechanisms deserve further investigation, and the TRPM8 antagonists deserve consideration for treatment of rhinitis in a therapeutic trial.

Original languageEnglish
Pages (from-to)e112-e116
JournalAmerican Journal of Rhinology and Allergy
Volume29
Issue number4
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Transient Receptor Potential Channels
Nasal Mucosa
Menthol
Nose
Methoxamine
Isometric Contraction
Electric Stimulation
Hypersensitivity
Parasympatholytics
Airway Resistance
Adrenergic Antagonists
Cilia
Rhinitis
Nerve Fibers
Adrenergic Agents
Connective Tissue
Inhalation
Immunohistochemistry

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Identification of the cold receptor TRPM8 in the nasal mucosa. / Liu, Shao Cheng; Lu, Hsuan Hsuan; Cheng, Li Hsiang; Chu, Yueng Hsiang; Lee, Fei Peng; Wu, Chi Chung; Wang, Hsing Won.

In: American Journal of Rhinology and Allergy, Vol. 29, No. 4, 01.07.2015, p. e112-e116.

Research output: Contribution to journalArticle

Liu, Shao Cheng ; Lu, Hsuan Hsuan ; Cheng, Li Hsiang ; Chu, Yueng Hsiang ; Lee, Fei Peng ; Wu, Chi Chung ; Wang, Hsing Won. / Identification of the cold receptor TRPM8 in the nasal mucosa. In: American Journal of Rhinology and Allergy. 2015 ; Vol. 29, No. 4. pp. e112-e116.
@article{203fef4c7cfa4dd4b19f0f1f4d04fb64,
title = "Identification of the cold receptor TRPM8 in the nasal mucosa",
abstract = "Background: The transient receptor potential channel melastatin 8 (TRPM8) has been proposed to be a cold receptor. However, its distribution and physiologic role in the nose is not yet fully explored. Objective: We investigated the expression of TRPM8 in human nasal mucosa and its function when using the TRPM8 agonist. Methods: Immunohistochemistry was used to study TRPM8 receptors in the nasal mucosa from patients with and those without allergic rhinitis (AR). By using isometric contraction studies, we also tested the effectiveness of the TRPM8 agonist menthol on nasal mucosa. Changes in nasal mucosal contractility in response to the application of the adrenergic agent methoxamine were also measured. We explored the effect of menthol on electrical field stimulation (EFS) induced nasal mucosal contractions. Results: TRPM8 immunoreactivity was present principally in the nasal cilia, epithelium, and subepithelium around the glands. Except for nerve fibers, no obvious TRPM8-immunoreactive cells were detected in connective tissues. The immunoreactivity revealed no significant difference between patients with AR and those without AR. Adding menthol had a negligible effect on the basal tension of the nasal mucosa, but higher doses of menthol had a significant spasmolytic effect on nasal mucosa precontracted with methoxamine. Menthol inhibited the spike contraction induced by EFS, even at low doses. Conclusions: The finding of the TRPM8 immunoreactivity underlines the important physiologic role of the nose in temperature regulation, both in patients with allergy and those without allergy. Isometric contraction studies demonstrate the role of TRPM8 in regulating nasal patency and airway resistance. The antiadrenergic effect of menthol showed an effect apparently opposite that of clinical observations, that we usually feel decongested after menthol inhalation. The underlying mechanisms deserve further investigation, and the TRPM8 antagonists deserve consideration for treatment of rhinitis in a therapeutic trial.",
author = "Liu, {Shao Cheng} and Lu, {Hsuan Hsuan} and Cheng, {Li Hsiang} and Chu, {Yueng Hsiang} and Lee, {Fei Peng} and Wu, {Chi Chung} and Wang, {Hsing Won}",
year = "2015",
month = "7",
day = "1",
doi = "10.2500/ajra.2015.29.4202",
language = "English",
volume = "29",
pages = "e112--e116",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Identification of the cold receptor TRPM8 in the nasal mucosa

AU - Liu, Shao Cheng

AU - Lu, Hsuan Hsuan

AU - Cheng, Li Hsiang

AU - Chu, Yueng Hsiang

AU - Lee, Fei Peng

AU - Wu, Chi Chung

AU - Wang, Hsing Won

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background: The transient receptor potential channel melastatin 8 (TRPM8) has been proposed to be a cold receptor. However, its distribution and physiologic role in the nose is not yet fully explored. Objective: We investigated the expression of TRPM8 in human nasal mucosa and its function when using the TRPM8 agonist. Methods: Immunohistochemistry was used to study TRPM8 receptors in the nasal mucosa from patients with and those without allergic rhinitis (AR). By using isometric contraction studies, we also tested the effectiveness of the TRPM8 agonist menthol on nasal mucosa. Changes in nasal mucosal contractility in response to the application of the adrenergic agent methoxamine were also measured. We explored the effect of menthol on electrical field stimulation (EFS) induced nasal mucosal contractions. Results: TRPM8 immunoreactivity was present principally in the nasal cilia, epithelium, and subepithelium around the glands. Except for nerve fibers, no obvious TRPM8-immunoreactive cells were detected in connective tissues. The immunoreactivity revealed no significant difference between patients with AR and those without AR. Adding menthol had a negligible effect on the basal tension of the nasal mucosa, but higher doses of menthol had a significant spasmolytic effect on nasal mucosa precontracted with methoxamine. Menthol inhibited the spike contraction induced by EFS, even at low doses. Conclusions: The finding of the TRPM8 immunoreactivity underlines the important physiologic role of the nose in temperature regulation, both in patients with allergy and those without allergy. Isometric contraction studies demonstrate the role of TRPM8 in regulating nasal patency and airway resistance. The antiadrenergic effect of menthol showed an effect apparently opposite that of clinical observations, that we usually feel decongested after menthol inhalation. The underlying mechanisms deserve further investigation, and the TRPM8 antagonists deserve consideration for treatment of rhinitis in a therapeutic trial.

AB - Background: The transient receptor potential channel melastatin 8 (TRPM8) has been proposed to be a cold receptor. However, its distribution and physiologic role in the nose is not yet fully explored. Objective: We investigated the expression of TRPM8 in human nasal mucosa and its function when using the TRPM8 agonist. Methods: Immunohistochemistry was used to study TRPM8 receptors in the nasal mucosa from patients with and those without allergic rhinitis (AR). By using isometric contraction studies, we also tested the effectiveness of the TRPM8 agonist menthol on nasal mucosa. Changes in nasal mucosal contractility in response to the application of the adrenergic agent methoxamine were also measured. We explored the effect of menthol on electrical field stimulation (EFS) induced nasal mucosal contractions. Results: TRPM8 immunoreactivity was present principally in the nasal cilia, epithelium, and subepithelium around the glands. Except for nerve fibers, no obvious TRPM8-immunoreactive cells were detected in connective tissues. The immunoreactivity revealed no significant difference between patients with AR and those without AR. Adding menthol had a negligible effect on the basal tension of the nasal mucosa, but higher doses of menthol had a significant spasmolytic effect on nasal mucosa precontracted with methoxamine. Menthol inhibited the spike contraction induced by EFS, even at low doses. Conclusions: The finding of the TRPM8 immunoreactivity underlines the important physiologic role of the nose in temperature regulation, both in patients with allergy and those without allergy. Isometric contraction studies demonstrate the role of TRPM8 in regulating nasal patency and airway resistance. The antiadrenergic effect of menthol showed an effect apparently opposite that of clinical observations, that we usually feel decongested after menthol inhalation. The underlying mechanisms deserve further investigation, and the TRPM8 antagonists deserve consideration for treatment of rhinitis in a therapeutic trial.

UR - http://www.scopus.com/inward/record.url?scp=84944054476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944054476&partnerID=8YFLogxK

U2 - 10.2500/ajra.2015.29.4202

DO - 10.2500/ajra.2015.29.4202

M3 - Article

C2 - 26163239

AN - SCOPUS:84944054476

VL - 29

SP - e112-e116

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 4

ER -